UVE Stock Cash Flow Statements

Universal Insurance Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Universal Insurance Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31

cash flows from operating activities:
net cash from operating activities	106,223,000	186,769,000	-101,339,000	82,916,000	340,000	69,231,000	51,657,000	-50,257,000	101,358,000	-2,267,000	252,505,000	-27,081,000	-39,602,000	16,860,000	195,855,000	61,265,000	-144,197,000	-17,302,000	145,204,000	45,643,000	28,009,000	601,000	24,537,000	31,451,000	5,651,000	66,373,000	105,755,000	52,326,000	-41,185,000	145,230,000					-21,911,000	33,635,000	-10,558,000	35,708,000	68,339,000	29,857,000	-30,646,000	-5,579,000	42,773,000	150,411,000	-2,898,000	13,105,000	36,516,000	95,274,000	-65,845,000	-39,255,000	85,130,000	130,099,000	-141,101,446	34,887,107	40,925,825	56,052,966
capex	-977,000	-1,227,000	-891,000	-3,298,000	-1,150,000	-1,007,000	-1,172,000	-690,000	-511,000	-595,000	-1,608,000	-2,185,000	-2,346,000	-1,856,000	-1,813,000	-1,211,000	-2,636,000	-4,367,000	-5,508,000	-4,705,000	-1,591,000	-1,693,000	-1,662,000	-6,368,000	-590,000	-2,117,000	-2,710,000	-1,314,000	-963,000	-898,000					-1,559,000	-2,896,000	0	0	-357,000	-751,000	-264,000	-238,000	-439,000	-409,000	0	-138,000	0	-1,542,000	0	-590,000	0	0	0	0	0	0
free cash flows	105,246,000	185,542,000	-102,230,000	79,618,000	-810,000	68,224,000	50,485,000	-50,947,000	100,847,000	-2,862,000	250,897,000	-29,266,000	-41,948,000	15,004,000	194,042,000	60,054,000	-146,833,000	-21,669,000	139,696,000	40,938,000	26,418,000	-1,092,000	22,875,000	25,083,000	5,061,000	64,256,000	103,045,000	51,012,000	-42,148,000	144,332,000					-23,470,000	30,739,000	-10,558,000	35,708,000	67,982,000	29,106,000	-30,910,000	-5,817,000	42,334,000	150,002,000	-2,898,000	12,967,000	36,516,000	93,732,000	-65,845,000	-39,845,000	85,130,000	130,099,000	-141,101,446	34,887,107	40,925,825	56,052,966
cash flows from investing activities:
proceeds from sale of property and equipment	3,000	9,000	11,000	50,000	8,000	10,000	15,000	9,000	32,000	64,000	0	1,000	130,000	4,000	12,000	16,000	41,000	119,000	11,000	11,000	11,000	9,000	10,000	8,000	5,000	13,000	5,000	12,000	6,000	2,000	5,000				31,000	4,000	54,000	0	13,000	17,000	3,000	0			10,000	0
purchases of property and equipment	-977,000	-1,227,000	-891,000	-3,298,000	-1,150,000	-1,007,000	-1,172,000	-690,000	-511,000	-595,000	-1,608,000	-2,185,000	-2,346,000	-1,856,000	-1,813,000	-1,211,000	-2,636,000	-4,367,000	-5,508,000	-4,705,000	-1,591,000	-1,693,000	-1,662,000	-6,368,000	-590,000	-2,117,000	-2,710,000	-1,314,000	-963,000	-898,000	-2,182,000	-2,404,000	-1,909,000	-1,728,000	-1,559,000	-2,896,000										-138,000
purchases of equity securities	-16,425,000	-2,006,000	-1,060,000	-977,000	-897,000	-7,738,000	-15,464,000	-9,356,000	-8,896,000	-12,460,000	-25,940,000	-29,333,000	-8,915,000	-32,340,000	-6,017,000	-8,175,000	-105,120,000	-1,000,000	0	-10,145,000	-260,000	-201,000	-193,000	-697,000	-2,235,000	-4,462,000	-9,249,000	-9,857,000	-42,232,000	-33,795,000	-20,274,000	-11,147,000	-15,089,000	-20,178,000		-10,146,000
purchases of available-for-sale debt securities	-135,043,000	-75,009,000	-34,817,000	-109,615,000	-42,864,000	-30,862,000	-46,462,000	-26,236,000	-21,223,000	-43,889,000	-77,736,000	-57,163,000	-95,476,000	-117,554,000	-58,525,000	-178,828,000	-339,203,000	-643,981,000	-29,663,000	-61,782,000	-27,419,000	-50,500,000	-88,626,000	-55,102,000		-143,879,000	-83,742,000	-121,996,000
proceeds from sales of equity securities			1,278,000	2,910,000	2,265,000	5,597,000	34,444,000	2,789,000	7,511,000	8,975,000	2,760,000	14,932,000	31,452,000	48,486,000	3,589,000	1,576,000					543,000	0	11,976,000	17,161,000	0	4,158,000	3,082,000	1,045,000	2,613,000	18,056,000	13,739,000	3,053,000	30,556,000	13,210,000		0
proceeds from sales of available-for-sale debt securities	20,866,000	4,610,000	18,000	3,700,000	15,237,000	290,000	394,000	3,301,000	4,584,000	5,321,000	6,994,000	12,540,000	20,450,000	15,538,000	33,523,000	27,455,000	250,624,000	729,344,000	18,489,000	9,979,000	4,749,000	29,836,000	28,655,000	14,550,000	1,790,000	13,579,000	19,758,000	99,464,000
proceeds from sale of private equity limited partnership
maturities of available-for-sale debt securities	57,703,000	32,075,000	17,359,000	32,849,000	31,406,000	34,644,000	15,478,000	27,554,000	9,679,000	25,608,000	20,917,000	12,766,000	19,446,000	16,782,000	28,135,000	25,178,000	24,439,000	44,329,000	38,680,000	32,534,000	45,172,000	31,779,000	31,890,000	36,635,000	28,159,000	18,708,000	39,117,000	25,363,000
net cash from investing activities	-58,964,000	-41,548,000	-20,866,000	-74,381,000	-789,000	934,000	-12,767,000	-2,629,000	-8,830,000	-16,976,000	-74,613,000	-48,442,000	-34,819,000	-62,091,000	-1,096,000	-131,398,000	-90,297,000	124,438,000	22,009,000	-34,108,000	21,205,000	9,230,000	-7,562,000	5,453,000	-61,711,000	-118,284,000	-23,974,000	-8,317,000	-90,825,000	-15,213,000	-27,422,000	-29,450,000	-49,989,000	-67,450,000	44,148,000	-37,976,000	-46,116,000	-52,842,000	25,792,000	-4,022,000	15,507,000	-27,067,000	-326,717,000	-14,406,000	-351,000	-138,000	-685,000	-1,524,000	-783,000	-590,000	-559,000	-399,000	-124,772	-275,994	451,219	-24,683,731
cash flows from financing activities:
preferred stock dividend	-2,000	-3,000	-2,000	-3,000	-2,000	-3,000	-2,000	-3,000	-2,000	-3,000	-2,000	-3,000	-2,000	-3,000	-2,000	-3,000	-2,000	-3,000	-2,000	-3,000	-2,000	-3,000	-2,000	-3,000	-2,000	-3,000	-2,000	-3,000	-2,000	-3,000	-3,000	-2,000	-2,000	-3,000	-3,000	-2,000	-3,000	-2,000	-3,000	-5,000	-14,000	-5,000	-5,000	-5,000	-23,000	-5,000	-5,000	-254,000	-5,000	-5,000	-5,000	-5,000	-4,988	-4,987	-4,988	-4,987
common stock dividend	-4,515,000	-4,841,000	-8,527,000	-4,639,000	-8,600,000	-4,794,000	-4,905,000	-4,980,000	-8,894,000	-4,906,000	-4,945,000	-5,029,000	-9,087,000	-5,003,000	-5,018,000	-5,083,000	-9,031,000	-5,111,000	-5,144,000	-5,261,000	-9,488,000	-5,465,000	-5,533,000	-5,620,000	-10,108,000	-5,579,000	-4,909,000	-4,912,000	-14,198,000	0	-14,364,000	-4,913,000	0	-4,915,000	-13,767,000	-4,283,000	-12,273,000	-3,503,000	-1,000	-3,463,000	-8,149,000	-3,496,000			-11,444,000	-3,213,000			-8,811,000	0			-3,916,726	-3,916,724
purchase of treasury stock inclusive of excise taxes paid				-4,508,000
payments related to tax withholding for share-based compensation	-23,000	-1,267,000	-1,419,000		-25,000	0	0	-314,000	-209,000	0	0	-209,000	-272,000	0	-289,000	-495,000	-62,000	-183,000	-424,000	-646,000	-631,000	-263,000	-413,000	-2,402,000	-5,163,000	-968,000	-1,790,000	-4,793,000	-5,856,000	0	-546,000	-74,000	-934,000	-3,897,000	-1,946,000	-404,000	-5,251,000	-122,000	-4,174,000	-8,108,000	-433,000	-98,000	-1,558,000	-1,072,000	0	0
repayment of debt	-368,000	-367,000	-368,000	-368,000	-367,000	-368,000	-368,000	-368,000	-368,000	-368,000	-368,000	-367,000	-368,000	-368,000	-367,000	-368,000	-367,000	-368,000	-368,000	-367,000	-368,000	-368,000	-367,000	-368,000	-368,000	-367,000	-368,000	-368,000	-367,000	-368,000	-368,000	-368,000	-332,000	-1,068,000	-367,000	-368,000			-6,367,000	-368,000	-368,000	-368,000				-368,000	-368,000	-367,000		-368,000
net cash from financing activities	-12,335,000	-6,478,000	-18,032,000	-9,518,000	-12,630,000	-17,462,000	-11,363,000	-5,665,000	-11,325,000	-7,696,000	-8,848,000	-9,587,000	86,906,000	-6,738,000	-5,676,000	-6,194,000	-11,882,000	-15,550,000	-15,967,000	-12,864,000	-26,743,000	-31,807,000	-20,422,000	-18,271,000	-29,801,000	-6,888,000	-15,366,000	-12,822,000	-20,680,000	-9,336,000	-14,848,000	-6,590,000	-3,664,000	-13,267,000	-26,997,000	-7,215,000			-15,545,000	-20,339,000	-4,872,000	-10,925,000	-18,075,000	-521,000	-15,034,000	-3,617,000	-5,474,000	2,533,000	-18,585,000	11,944,000	-8,945,000	3,828,000	-6,160,345
cash and cash equivalents and restricted cash and cash equivalents:
net increase during the period	34,924,000	138,743,000	-140,237,000	-983,000	-13,079,000	52,703,000	27,527,000	-58,551,000	81,203,000	-26,939,000	169,044,000	-85,110,000	12,485,000	-51,969,000	189,083,000	-76,327,000	-246,376,000	91,586,000	151,246,000	-1,329,000	22,471,000	-21,976,000	-3,447,000	18,633,000	-85,861,000	-58,799,000	66,415,000	31,187,000
balance, beginning of period	0	262,076,000	0	399,941,000	0	0	0	391,341,000	0	0	0	253,143,000	0	0	0	179,871,000	0	0	0	184,744,000	0	0	0	169,063,000	0	0	0	216,121,000
balance, end of period	34,924,000	400,819,000	-140,237,000	398,958,000	-13,079,000	52,703,000	27,527,000	332,790,000	81,203,000	-26,939,000	169,044,000	168,033,000	12,485,000	-51,969,000	189,083,000	103,544,000	-246,376,000	91,586,000	151,246,000	183,415,000	22,471,000	-21,976,000	-3,447,000	187,696,000	-85,861,000	-58,799,000	66,415,000	247,308,000
net income																																			29,152,000	30,298,000	20,972,000	21,341,000	17,126,000	13,549,000	15,582,000	14,407,000	17,029,000	11,959,000	4,406,000	8,256,000	7,777,000	9,873,000	-2,313,000	975,000	7,549,000	13,898,000	4,828,100	14,444,684	9,404,009	8,306,969
adjustments to reconcile net income to net cash from operating activities:
bad debt expense																																			114,000	300,000	169,000	96,000	95,000	71,000	65,000	109,000	130,000	124,000	95,000	121,000			31,000	228,000	230,000	164,000	-351,119	1,036,103	428,293	201,523
depreciation and amortization																																			782,000	448,000
amortization of share-based compensation																																			4,820,000	4,973,000	3,576,000	3,556,000	3,525,000	1,685,000
amortization of debt issuance costs
benefit from (or reversal of) credit losses on available-for-sale debt securities
book overdraft increase																																			-3,728,000	1,003,000	63,000	1,549,000	1,327,000	-11,962,000
net realized (gains) losses on sale of investments
net change in unrealized (gains) losses on investments																																									62,000	-15,000
amortization of premium/accretion of discount																																			491,000	443,000	576,000	533,000	508,000	499,000	519,000	776,000	245,000	42,000
deferred income taxes																																			-346,000	-1,875,000	289,000	435,000	-115,000	509,000	1,635,000	1,564,000	308,000	3,856,000	-2,993,000	5,095,000	-3,871,000	5,582,000	1,129,000	-7,063,000	-4,051,000	442,000	-3,111,642	1,769,454	-1,871,037	1,879,864
excess tax (benefit) shortfall from share-based compensation
gain on disposal of assets																																										0
net change in assets and liabilities relating to operating activities:
prepaid reinsurance premiums																																			-1,433,000	-2,501,000	4,817,000	-1,511,000	42,215,000	5,188,000	9,292,000	5,435,000	-3,462,000	-12,558,000	8,978,000	-1,064,000	28,530,000	-33,270,000	8,247,000	2,240,000	-25,187,000	-7,309,000	7,277,467	4,723,213	-12,064,021	-20,728,351
reinsurance recoverable																																			13,282,000	2,022,000	1,054,000	21,325,000
income taxes payable																																			-359,000	-808,000	2,340,000	-284,000	-508,000	4,691,000	1,423,000	1,305,000	348,000	-850,000	681,000	-3,002,000	851,000	-12,331,000	-3,443,000	2,898,000	2,586,000	2,612,000	4,817,770	-322,037	3,306,734	110,595
premiums receivable																																			5,530,000	2,465,000	3,533,000	263,000	-6,992,000	-1,715,000	5,890,000	4,338,000	-6,142,000	-830,000	5,825,000	214,000	-10,931,000	303,000	4,723,000	1,212,000	-8,833,000	43,000	5,244,771	-200,956	-11,070,214	-1,547,897
accrued investment income																																			76,000	-210,000	-72,000	-128,000	2,000	-32,000	178,000	-169,000	-749,000	20,000	51,000	75,000	159,000	40,000		-401,000
income taxes recoverable																																			5,544,000	1,985,000	-2,761,000	-90,000	3,375,000	1,953,000	6,346,000	-5,420,000	-7,100,000	616,000	-2,188,000	218,000	446,000	-1,070,000					0	-2	-49,221	3,261,097
deferred policy acquisition costs																																			2,984,000	-822,000	2,172,000	245,000	-12,184,000	6,000	1,054,000	288,000	136,000	-95,000	737,000	-275,000	-5,946,000	1,198,000	17,000	-987,000	-1,886,000	-694,000	3,407,170	1,189,041	-1,605,498	-2,971,768
other assets																																			338,000	19,000	28,000	-598,000	-520,000	350,000	994,000	-604,000	-922,000	73,000	-31,000	345,000	72,000	-55,000	702,000	508,000	-702,000	-1,234,000	-628,579	274,864	-544,583	119,315
unpaid losses and loss adjustment expenses																																			-2,219,000	-11,058,000	-2,562,000	-7,710,000	-5,932,000	-8,665,000	1,848,000	-8,886,000	-16,269,000	-10,712,000	20,567,000	8,049,000	-7,675,000	-14,915,000	24,261,000	7,579,000	-2,875,000	-679,000	22,070,987	7,954,089	-2,832,909	4,538,917
unearned premiums																																			-21,285,000	7,769,000	-16,127,000	-834,000	27,948,000	1,273,000	-23,955,000	-13,244,000	22,645,000	9,971,000	-20,643,000	1,762,000	35,911,000	11,199,000	-15,937,000	-4,489,000	43,346,000	8,588,000	-17,969,898	-9,431,253	57,418,688	19,946,466
commission payable
reinsurance payable																																			-51,842,000	-6,311,000	-36,185,000	-17,844,000	26,441,000	7,422,000	-32,341,000	-16,126,000	29,819,000	19,621,000	-38,674,000	-149,853,000	159,310,000	26,980,000	-41,307,000	-1,307,000	19,025,000	35,533,000	-29,985,847	-18,882,727	-2,393,421	16,103,884
other liabilities and accrued expenses																																			-872,000	9,729,000	2,260,000	7,259,000	-966,000	-5,779,000	679,000	6,460,000	923,000	-3,259,000	18,000	4,344,000
advance premium																																			-1,216,000	-3,274,000	-3,383,000	-1,369,000	-2,742,000	2,454,000	-733,000	-1,979,000	-1,538,000	12,187,000	-3,446,000	-7,138,000	-5,495,000	11,711,000	-2,249,000	-4,191,000	-4,228,000	10,218,000	-1,117,777	898,564	-3,298,375	6,278,770
purchases of other investments
purchases of investment real estate													0				-1,000				0	0	-149,000	-734,000	-822,000	-4,284,000	-235,000	-1,034,000	-2,195,000	-1,264,000	-1,096,000	-2,326,000	-53,000	-2,021,000	-332,000	-6,000
debt issuance costs paid									-9,000	0	-31,000	-100,000
purchase of treasury stock, inclusive of excise taxes paid
cash and cash equivalents, and restricted cash and cash equivalents:
supplemental cash and non-cash flow disclosures:
interest paid																															59,000	59,000	107,000	196,000	196,000	200,000			395,000	433,000		423,000
income taxes paid																															5,110,000	22,487,000			13,829,000	18,275,000			10,531,000	2,404,000	70,000	28,731,000
income tax refund																															-61,000	0
proceeds from sales of investment real estate													0	0	0	2,591,000					0	0
proceeds from sale of assets held for sale													440,000
proceeds from issuance of long-term debt
purchase of treasury stock					-3,636,000	-12,297,000			-1,843,000	-2,419,000	-3,502,000	-3,879,000	0	-1,364,000	0	-245,000	-2,420,000	-9,885,000	-10,029,000	-6,587,000	-16,254,000	-25,708,000	-14,107,000	-10,117,000	-14,160,000	0	-8,370,000	-2,746,000	-257,000	-8,965,000	-95,000	-1,488,000	-5,053,000	-1,874,000	-10,984,000	-2,589,000	0	-9,999,000	-5,000,000	-14,737,000	-1,000	-4,288,000
net change in unrealized gains of equity securities
other																																			18,000	0	-6,000	30,000	7,000	-12,000									4,000	0	-859,000	838,000	-605,857	-5,900	0	-15,035
issuance of common stock																																			0	7,000									0	116,000	0	91,000					7,000	0	0	7,000
proceeds from the issuance of common stock for stock option exercises
reversal of benefit from credit losses on available-for-sale debt securities
net realized (gains) losses sale on investments
maturities of short-term investments																													0	0	0	0				24,991,000
issuance of common stock for stock option exercises																					0	0	0	239,000	0	29,000
amortization of original issue discount on debt																																			94,000	92,000	181,000	179,000	230,000	250,000
reinsurance receivable																																			-187,000	550,000	5,067,000	13,817,000								95,136,000	-109,870,000	39,411,000
accounts payable																																			-1,204,000	-399,000	-336,000	-352,000	310,000	1,058,000	-422,000	-1,147,000	694,000	-52,000	116,000	-1,090,000	278,000	750,000	28,000	-1,406,000	421,000	1,504,000	271,198	-1,326,619	848,643	801,445
purchases of short-term investments																																				4,000
maturities of available-for-sale short-term investments																										0
accretion of deferred credit																																			-94,000	-92,000	-181,000	-179,000	-230,000	-250,000	-252,000	-248,000
net realized (gains) losses sale of securities
purchases of available -for-sale debt securities
sale of treasury stock																															0	0
excess tax benefit (shortfall) from share-based compensation
net realized (gains) losses on investments																																			-768,000	-11,000	-274,000	-501,000	-3,950,000	-902,000	-1,242,000	-56,000			-353,000	3,142,000
excess tax (benefits) shortfall from share-based compensation																																			-69,000	-424,000	-541,000	-123,000	0	-6,342,000
payments to acquire a business																																			0	0
purchases of fixed maturities																													-66,011,000	-47,076,000	-41,170,000	-37,348,000	-145,724,000	-95,889,000		-71,798,000																			-78,713,575	-50,426,894
proceeds from sales of fixed maturities																													6,536,000	13,136,000	7,052,000	5,059,000	57,755,000	16,152,000		12,014,000																			90,915,664	25,322,048
proceeds from sales of short-term investments																																		12,500,000		0
maturities of fixed maturities																													21,421,000	36,626,000	16,504,000	15,632,000	11,975,000	10,504,000		9,857,000
purchase of preferred stock																																			1,000	0
excess tax benefits (shortfall) from share-based compensation																															409,000	255,000	-308,000	-1,510,000	69,000	424,000	541,000	123,000	0	6,342,000
borrowings under promissory note																																				0
net increase in cash and cash equivalents																													-152,690,000	120,681,000	-99,511,000	-10,042,000	55,249,000	-36,980,000	-4,760,000	-11,556,000			78,586,000	5,496,000	-20,011,000	-43,571,000	-302,019,000	135,484,000	-18,283,000	9,350,000	30,357,000	96,283,000	-85,213,000	-27,901,000	75,626,000	133,528,000	-147,386,563	32,527,259	33,903,454	35,617,023
cash and cash equivalents at beginning of period																													0	0	0	0	0	197,014,000	0	0			0	117,275,000	0	0	0	347,392,000	0	0	0	229,685,000	-13,940,000	0	0	147,585,000	0	0	0	192,924,291
cash and cash equivalents at end of period																													-152,690,000	120,681,000	-99,511,000	-10,042,000	55,249,000	160,034,000	-4,760,000	-11,556,000			78,586,000	122,771,000	-20,011,000	-43,571,000	-302,019,000	482,876,000	-18,283,000	9,350,000	30,357,000	325,968,000	-99,153,000	-27,901,000	75,626,000	281,113,000	-147,386,563	32,527,259	33,903,454	228,541,314
restricted cash and cash equivalents																																					3,962,000	-3,962,000	0	-35,000	0	53,000	0	30,356,000	62,127,000	-20,861,000	-26,096,000	30,134,000
other receivables																																			486,000	-676,000	462,000	271,000	-85,000	-636,000	666,000	896,000	-1,158,000	-273,000	1,126,000	357,000	-1,586,000	463,000	758,000	1,053,000	-1,454,000	-228,000	774,984	-483,125	1,654,063	864,550
proceeds received from issuance of contingently redeemable common stock
cash flows from operating activities																																25,998,000	108,902,000	43,737,000
purchase of trading securities																																									0	0	0	-26,009,000
proceeds from sales of trading securities																																									0	0	21,991,000	80,670,000
purchases of equity securities, available for sale																																									-7,508,000	-18,515,000													-44,850,634	-35,879,591
purchases of fixed maturities, available for sale																																									839,000	-13,180,000	-283,001,000	-9,988,000
purchases of short-term investments, available for sale
proceeds from sales of equity securities, available for sale																																									15,152,000	376,000													34,233,754	36,447,190
proceeds from sales of fixed maturities, available for sale
proceeds from sales of short-term investments, available for sale
maturities of fixed maturities, available for sale
maturities of short-term investments, available for sale
proceeds from borrowings																																									0	0
non-cash transfer of investments from trading to available for sale portfolio																																									0	0
net foreign currency (gains) losses on investments																																													0	0
purchase of property and equipment																																							-357,000	-751,000	-264,000	-238,000	-439,000	-409,000
proceeds received from issuance of common and contingently redeemable common stock
depreciation																																						294,000	271,000	280,000	267,000	248,000	248,000	249,000	215,000	215,000	211,000	199,000	260,000	80,000	117,000	182,000	99,342	433,792	151,213	146,812
purchases of available for sale equity securities																																							-8,469,000	-4,782,000
purchases of available for sale fixed maturities																																							-28,755,000	-20,475,000
proceeds from sales of available for sale equity securities																																							58,346,000	10,071,000
proceeds from sales of available for sale fixed maturities																																							1,000	4,370,000
maturities of available for sale fixed maturities																																							5,013,000	7,528,000
supplemental cash flow and non-cash disclosures:
reinsurance recoverables																																								31,750,000	-32,947,000	4,251,000	8,080,000	1,960,000	-8,391,000	34,659,000	-38,410,000	8,657,000	-8,161,000	-342,000	1,923,000	426,000	-12,215,642	-4,100,723	1,800,204	26,780,719
reinsurance receivables																																								-6,801,000	24,065,000	274,000	-20,062,000	19,854,000
amortization of stock-based compensation																																									1,778,000	1,711,000	1,760,000	1,168,000	1,271,000	867,000	680,000	1,012,000
excess tax (benefits) shortfall from stock-based compensation																																									-307,000	-48,000	-155,000	151,000	-5,000	1,694,000	-71,000	142,000
maturities of fixed maturity securities, available for sale																																									7,285,000	5,021,000
excess tax benefits (shortfall) from stock-based compensation																																									308,000	47,000	155,000	-151,000	5,000	-1,694,000	71,000	-142,000
interest																																												87,000	87,000	86,000	136,000	105,000	112,000	180,000
amortization of original issue discount																																										248,000
bank overdraft increase																																										-2,717,000	-2,143,000	1,075,000
net realized																																												16,037,000
net change in unrealized																																												-7,874,000
transfer of investments to available for sale portfolio																																												4,009,000
transfer of investments from trading securities portfolio																																												-4,009,000
repayments of debt																																												-368,000
supplemental cash flow disclosures:
income taxes																																												4,313,000	5,698,000	500,000	7,783,000	14,170,000	5,568,000	430,000	7,033,000	6,050,000
purchases of fixed maturities, available-for-sale																																																					0
proceeds from sales of fixed maturities, available-for-sale																																																					0
net unrealized (gains) losses on investments																																														-8,091,000	5,788,000	-9,187,000
amortization of premium / accretion of discount																																														-26,000	18,000	3,000		15,000	13,000	157,000	140,015	133,812	164,010	107,000
proceeds from sale of trading securities																																														93,642,000	97,615,000	119,686,000		207,543,000
purchases of trading securities																																														-53,686,000	-93,271,000	-107,313,000		-245,016,000
bank overdraft																																														1,547,000	-1,039,000	3,205,000		12,317,000	-4,266,000	3,833,000	-1,748,415	2,205,502	-2,887,074	5,163,241
supplemental cash flow disclosures
bad debt (recovery) expense																																																-80,000
net realized losses (gains) on investments																																																7,449,000
net foreign currency (gains) on investments																																																-23,000
other accrued expenses																																																-1,274,000	2,458,000	2,300,000	-3,447,000	319,000	477,815	3,816,453	-613,582	-1,281,469
proceeds from sale of property, plant and equipment																																																18,000		0
purchases of property, plant and equipment																																																-1,542,000		-590,000
supplemental cash flow disclosure
dividends accrued																																																4,012,000							-783,202	4,699,926
net realized gains on investments																																																	10,146,000	-5,884,000	-2,960,000	-3,652,000
net unrealized losses (gains) on investments																																																	-4,627,000
net foreign currency gains on investments																																																			0	-71,000
excess tax benefits from stock-based compensation																																																					438,945	2
tax withholding payments related to stock-based compensation
supplemental cashflow disclosures:
amortization of cost of stock options																																																		501,000	202,000	254,000	342,356	313,343	975,225	477,781
amortization of non-vested shares																																																		468,000
net foreign currency losses (gains) on investments
purchase of treasury shares
net unrealized losses on investments
other-than-temporary impairment of investments
amortization of restricted stock grants																																																				144,000	162,320	234,267	231,723	224,382
net unrealized gains on investments																																																				-2,588,000
proceeds from sales of debt securities, trading																																																				73,240,000
purchases of equity securities, trading																																																				-48,350,000
proceeds from sales of equity securities, trading																																																				46,342,000
capital expenditures and building improvements																																																				-399,000		-387,449	-38,222	-146,484
treasury shares on option exercise																																																					-568,513	0	0	-3,723,972
tax benefit on exercise of stock options																																																								-3,174,153
repayments of loans payable																																																					-367,648	-367,647	-367,647	-367,647
foreign currency gains on investments																																																					-308,529	7,846	-158,642	-683,733
deferred ceding commission
purchase of fixed maturities, trading
proceeds from sales of fixed maturities, trading																																																					70,663,953
purchase of equity securities, trading
proceeds from sale of equity securities, trading																																																					83,353,876
proceeds from sale of property																																																					0	17,500
purchase of property, plant and equipment
purchases of fixed maturities, held-to-maturity
repurchase of treasury stock
realized gains on investments																																																						-3,841,335	-4,457,307	-3,694,717
unrealized gains on investments
purchases of fixed maturities, trading
purchase of real estate																																																						0
purchases of equity securities, available-for-sale
proceeds from sales of equity securities, available-for-sale
non cash items:
building improvements
net cash from in financing activities																																																							-7,473,590	4,247,788
allowance for doubtful accounts
non cash items

We provide you with 20 years of cash flow statements for Universal Insurance stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Universal Insurance stock. Explore the full financial landscape of Universal Insurance stock with our expertly curated income statements.

The information provided in this report about Universal Insurance stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.